scholarly journals Lessons Learned from Randomized Trials and Recent Experience with Health Information Technology: Promising Interventions Meet Real-World Patient Care

2010 ◽  
Vol 16 (9) ◽  
pp. 718-728
Author(s):  
Kathleen A. Fairman ◽  
Frederic R. Curtiss
2017 ◽  
Vol 34 (2) ◽  
pp. 457-486 ◽  
Author(s):  
Alain Pinsonneault ◽  
Shamel Addas ◽  
Christina Qian ◽  
Vijay Dakshinamoorthy ◽  
Robyn Tamblyn

2017 ◽  
pp. 694-714
Author(s):  
Kijpokin Kasemsap

This chapter explains the perspectives on global health, the overview of health information technology (health IT), the applications of electronic health record (EHR), and the importance of health IT in global health care. Health IT is the area of IT involving the design, development, creation, utilization, and maintenance of information systems for the health care industry. Health IT makes it possible for health care providers to better manage patient care through the secure use and sharing of health information. Effective health IT can lower costs, improve efficiency, and reduce medical error, while providing better patient care and service. The chapter argues that utilizing health IT has the potential to enhance health care performance and reach strategic goals in global health care.


Author(s):  
Kijpokin Kasemsap

This chapter explains the perspectives on global health, the overview of health information technology (health IT), the applications of electronic health record (EHR), and the importance of health IT in global health care. Health IT is the area of IT involving the design, development, creation, utilization, and maintenance of information systems for the health care industry. Health IT makes it possible for health care providers to better manage patient care through the secure use and sharing of health information. Effective health IT can lower costs, improve efficiency, and reduce medical error, while providing better patient care and service. The chapter argues that utilizing health IT has the potential to enhance health care performance and reach strategic goals in global health care.


2020 ◽  
Author(s):  
Moritz Esdar ◽  
Jan David Liebe ◽  
Johannes Thye ◽  
Birgit Babitsch ◽  
Ursula Hübner

BACKGROUND Large health organizations often struggle to build complex health information technology (HIT) solutions of high quality and are faced with ever growing pressure to continuously innovate their information systems. While achieving high quality HIT implementations requires change and, therefore, an innovative organization, innovation and change can also be regarded as a threat to a running system. Rather limited research has been conducted in this context that explores the relationship between the organization’s innovative capabilities and HIT quality in the sense of achieving high quality support of patient care. OBJECTIVE To explain how the different facets of organizational innovation capabilities are linked to HIT quality in order to eventually achieve better information provision in health care organizations. METHODS We designed a survey assessing various domains of HIT quality as well as the organization’s capacity for innovation and administered it to hospitals across Austria, Germany, and Switzerland. The results from 232 hospitals were used to fit a model that was specified to predict HIT quality domains as a function of multiple interrelationships among the facilitating constructs using partial least squares structural equation modeling (PLS-SEM). RESULTS The results from PLS-SEM indicated satisfactory values of the model parameters, including the convergent and discriminant validity for measuring the latent constructs that underlie the measures of HIT quality and of innovation capabilities. Pursuant to this model, HIT quality was expressed as the path from a “professional information management” explaining “HIT support of patient care” (R² = .55) to explaining “perceived goodness of information provision” (R² = .53) via “perceived HIT support”. “Innovation capabilities of the top management team” were strongly associated with the ones of the “IT department” and of the “organization at large”. These capabilities mainly acted on the “professionalism of information management” (R² = .73), particularly through the innovative attitude of the top management team and of the IT department as well as on the perceived HIT quality through an organization-wide culture of innovation. Based on these findings, we propose this model as the innovation and quality model of health information technology, the IQHIT model, which measures and explains the internal modes of action for HIT quality and for innovation capabilities as well as their interaction. CONCLUSIONS The IQHIT model combines individual associations that are well-known from the literature with the empirical evidence of the complex interplay of HIT quality and innovation. It highlights the key of the professionalism of information management to the quality with which patient care processes are supported by HIT and how innovation capabilities shape information management. The IQHIT model may serve to stimulate further scientific work also in the field of HIT adoption and diffusion as well as to provide practical advice on how to achieve good patient care with the help of health IT.


2020 ◽  
pp. 107815522090892
Author(s):  
Jennifer S Philippon ◽  
Carolyn L Kusoski ◽  
Julie M Kennerly-Shah ◽  
Janinah S Barreto

Purpose To describe the role of hematology/oncology clinical pharmacists in health information technology as well as their perceptions of the impact of technology expansion on patient care. Methods A single-center, web-based survey was distributed to 30 hematology/oncology clinical pharmacists by email over the two-week-period of 24 September 2018 to 8 October 2018. The anonymous survey was composed of 19 questions, with varying formats including multiple choice, fill-in-the-blank, and rank order. Primary endpoints were quantification of time spent in the electronic health record and perceptions on how technology expansion has impacted the safety, quality, and efficiency of patient care. Results Twenty-seven hematology/oncology clinical pharmacists (90% response rate) completed the survey in its entirety. Respondents reported that they spend an average of 84.1% of their work day in the electronic health record. Based on a 40-h work week, clinical pharmacists indicated that they spend approximately 32.2 h each week performing direct patient care tasks in the electronic health record compared to 3.7 h on indirect patient care tasks. All respondents reported a greater utilization of technology over the last five years, and most respondents felt that patient care is safer, of better quality, and more efficient with technology expansion. The majority of respondents (81.5%) indicated that clinical pharmacists have the best understanding of the health information technology system, followed by generalist pharmacists and informatics pharmacists. Conclusion The hematology/oncology clinical pharmacist is well positioned to serve as a health information technology leader on the interdisciplinary healthcare team.


2020 ◽  
Vol 11 (02) ◽  
pp. 295-302
Author(s):  
Stephanie J. Garcia ◽  
Teresa Zayas-Cabán ◽  
Robert R. Freimuth

Abstract Background Making genomic data available at the point-of-care and for research is critical for the success of the Precision Medicine Initiative (PMI), a research initiative which seeks to change health care by “tak(ing) into account individual differences in people's genes, environments, and lifestyles.” The Office of the National Coordinator for Health Information Technology (ONC) led Sync for Genes, a program to develop standards that make genomic data available when and where it matters most. This article discusses lessons learned from recent Sync for Genes activities. Objectives The goals of Sync for Genes were to (1) demonstrate exchange of genomic data using health data standards, (2) provide feedback for refinement of health data standards, and (3) synthesize project experiences to support the integration of genomic data at the point-of-care and for research. Methods Four organizations participated in a program to test the Health Level Seven International (HL7®) Fast Healthcare Interoperability Resources (FHIR®) standard, which supports sharing genomic data. ONC provided access to subject matter experts, resources, tools, and technical guidance to support testing activities. Three of the four organizations participated in HL7 FHIR Connectathons to test FHIR's ability to exchange genomic diagnostic reports. Results The organizations successfully demonstrated exchange of genomic diagnostic reports using FHIR. The feedback and artifacts that resulted from these activities were shared with HL7 and made publicly available. Four areas were identified as important considerations for similar projects: (1) FHIR proficiency, (2) developer support, (3) project scope, and (4) bridging health information technology and genomic expertise. Conclusion Precision medicine is a rapidly evolving field, and there is opportunity to continue maturing health data standards for the exchange of necessary genomic data, increasing the likelihood that the standard supports the needs of users.


Sign in / Sign up

Export Citation Format

Share Document